Resverlogix Provides Update on BETonMACE Phase 3 Epigenetics Trial

Ads

You May Also Like

Collegium Announces Promotion of Scott Dreyer to CCO

CANTON, Mass., July 10, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced ...

Neon Therapeutics Provides Business Update and Outlook for 2019

CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a ...

Argos Announces One-for-Twenty Reverse Stock Split

DURHAM, N.C., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...